Pillstats
Rx only · Injection · Intramuscular

Prochlorperazine Edisylate

Prochlorperazine Edisylate

15 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
15 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05AB04
RxCUI (US)8704
US makers15 labelers
Packages25
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

11K22K33K44K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
70K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it15 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown4SUPPLYING
Gland Pharma Limitedunknown3SUPPLYING
Mylan Institutional LLCunknown2SUPPLYING
Cosette Pharmaceuticals, Inc.unknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Eugia US LLCunknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown2SUPPLYING
Caplin Steriles Limitedunknown1SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown1SUPPLYING
Fosun Pharma USA Incunknown1SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Somerset Therapeutics, LLCunknown1SUPPLYING
Baxter Healthcare Corporationunknown1SUPPLYING
Civica, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 21, 2019
    RECALLRecall (Class I): PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure Pharmaceuticals Ltd., H…

    Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) . — Recalling firm: Heritage Pharmaceuticals, Inc. — Nationwide in the USA